Stay updated with breaking news from Roivant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Truist Financial reiterated their buy rating on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research report released on Monday, Benzinga reports. Truist Financial currently has a $23.00 price objective on the stock. A number of other research analysts have also recently issued reports on ROIV. TheStreet raised shares of Roivant Sciences from […]
Real-time index price for TSX Real Estate Capped Index (TTRE), along with buy or sell indicators, analysis, charts, historical performance, news and more
S&P Dow Jones Indices announced late Tuesday that Sunrun will replace PGT Innovations in the S&P SmallCap 600, effective prior to the market open on April 1.
NEW YORK, March 26, 2024 /PRNewswire/ -- Roivant Sciences Ltd will replace Sunrun Inc. in the S&P MidCap 400, and Sunrun will replace PGT Innovations Inc. in the S&P SmallCap 600 effective prior...
/PRNewswire/ -- Roivant Sciences Ltd (NASD:ROIV) will replace Sunrun Inc. (NASD:RUN) in the S&P MidCap 400, and Sunrun will replace PGT Innovations Inc....